Showing results (301-310 of 330) with videos related to
Sort By:
Pageof 33
International Journal of Cardiology|April 3, 2013
Non-HDL-cholesterol/HDL-cholesterol is a better predictor of metabolic syndrome and insulin resistance than apolipoprotein B/apolipoprotein A1Se Won Kim, Jae Hwan Jee, Hye Jeong Kim, et al.Atherosclerosis|March 25, 2014
Non-HDL cholesterol is an independent risk factor for aspirin resistance in obese patients with type 2 diabetesJong Dai Kim, Cheol-Young Park, Kue Jeong Ahn, et al.Cell Transplantation|July 1, 2014
Improved Insulin Secretion by Autologous Islet Transplantation, Compared to Oral Antidiabetic Agents, After Distal PancreatectomyJi Won Yoon, Hye Seung Jung, Jin Young Jang, et al.Endocrine|July 21, 2017
Hormetic effect of triiodothyronine in metabolically healthy obese personsJi Eun Jun, Tae Hyuk Kim, Seung-Eun Lee, et al.Endocrinology and Metabolism (Seoul, Korea)|February 5, 2024
Clinical Characteristics, Diagnosis, and Treatment of Thyroid Stimulating Hormone-Secreting Pituitary Neuroendocrine Tumor (TSH PitNET): A Single-Center ExperienceJung Heo, Yeon-Lim Suh, Se Hoon Kim, et al.Plos One|October 31, 2012
Regular exercise is associated with a reduction in the risk of NAFLD and decreased liver enzymes in individuals with NAFLD independent of obesity in Korean adultsJi Cheol Bae, Sunghwan Suh, Se Eun Park, et al.Diabetes & Metabolism Journal|May 23, 2014
Prevalence and determinants of diabetic nephropathy in Korea: Korea national health and nutrition examination surveyJae Hee Ahn, Ji Hee Yu, Seung-Hyun Ko, et al.Endocrinology and Metabolism (Seoul, Korea)|December 14, 2025
Efficacy and Safety of Stage 5 Connected Insulin Pens in Type 1 or Type 2 Diabetes: Randomized Controlled Trial ProtocolJi Yoon Kim, Nam Hoon Kim, Soo Heon Kwak, et al.The Journal of Clinical Investigation|July 19, 2014
Amyloidogenic peptide oligomer accumulation in autophagy-deficient β cells induces diabetesJinyoung Kim, Hwanju Cheon, Yeon Taek Jeong, et al.Diabetes & Metabolism Journal|June 26, 2019
Effectiveness and Safety of Adding Basal Insulin Glargine in Patients with Type 2 Diabetes Mellitus Exhibiting Inadequate Response to Metformin and DPP-4 Inhibitors with or without SulfonylureaYu Mi Kang, Chang Hee Jung, Seung Hwan Lee, et al.Pageof 33